To the top

Page Manager: Webmaster
Last update: 9/11/2012 3:13 PM

Tell a friend about this page
Print version

IGF-I in the clinics: Use… - University of Gothenburg, Sweden Till startsida
To content Read more about how we use cookies on

IGF-I in the clinics: Use in retinopathy of prematurity

Journal article
Authors Ann Hellström
D. Ley
I. Hansen-Pupp
B. Hallberg
L. A. Ramenghi
Chatarina Löfqvist
L. E. H. Smith
A. L. Hard
Published in Growth Hormone & Igf Research
Volume 30-31
Pages 75-80
ISSN 1096-6374
Publication year 2016
Published at Institute of Neuroscience and Physiology, Department of Clinical Neuroscience and Rehabilitation
Pages 75-80
Language en
Keywords Fetus, Preterm infant, Postnatal growth, IGF-1, Metabolism, Preterm morbidity, growth-factor-i, oxygen-induced retinopathy, factor-binding-proteins, vascular endothelial-cells, extremely preterm infants, retinal, neovascularization, saturation targets, human-fetus, glucose-transport, postnatal weight, Cell Biology
Subject categories Clinical Medicine


Retinopathy of prematurity is a potentially blinding disease, which is associated with low neonatal IGF-I serum concentrations and poor growth. In severe cases impaired retinal vessel growth is followed by pathologic neovascularization, which may lead to retinal detachment. IGF-I may promote growth even in catabolic states. Treating preterm infants with recombinant human (rh) IGF-I to concentrations normally found during gestation has been suggested to have a preventative effect on ROP. A recent phase 2 study treating infants (gestational age between 23 weeks + 0 days and 27 weeks +6 days) with rhIGF-I/IGF binding protein-3 until 30 postmenstrual weeks showed no effect on ROP but a 53% reduction in severe bronchopulmonary dysplasia and 44% reduction in severe intraventricular hemorrhage. Oxygen is a major risk factor for ROP and during the phase 2 study oxygen saturation targets were increased to 90-95%, due to national guidelines, which might have affected ROP rate and severity making increased IGF-I a weaker preventative factor for ROP.

Page Manager: Webmaster|Last update: 9/11/2012

The University of Gothenburg uses cookies to provide you with the best possible user experience. By continuing on this website, you approve of our use of cookies.  What are cookies?